VERQUVO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Vericiguat.
| Product ID | 0006-5030_15049ae3-29b9-496a-bf12-350978af10bb | 
| NDC | 0006-5030 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | VERQUVO | 
| Generic Name | Vericiguat | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2021-02-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA214377 | 
| Labeler Name | Merck Sharp & Dohme Corp. | 
| Substance Name | VERICIGUAT | 
| Active Ingredient Strength | 10 mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2021-02-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0006-5028 | VERQUVO | vericiguat | 
| 0006-5029 | VERQUVO | vericiguat | 
| 0006-5030 | VERQUVO | vericiguat | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VERQUVO  90764015  not registered Live/Pending | Bayer Aktiengesellschaft 2021-06-09 | 
|  VERQUVO  87952816  5810492 Live/Registered | Bayer Aktiengesellschaft 2018-06-07 |